Practice variation in anastomotic leak after esophagectomy: Unravelling differences in failure to rescue

Nenhuma Miniatura disponível
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCI LTD
Autores
UBELS, Sander
MATTHEE, Eric
VERSTEGEN, Moniek
KLARENBEEK, Bastiaan
BOUWENSE, Stefan
HENEGOUWEN, Mark I. van Berge
DAAMS, Freek
DEKKER, Jan Willem T.
DET, Marc J. van
ESSER, Stijn van
Citação
EJSO, v.49, n.5, p.974-982, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: Failure to rescue (FTR) is an important outcome measure after esophagectomy and reflects mortality after postoperative complications. Differences in FTR have been associated with hospital resection volume. However, insight into how centers manage complications and achieve their outcomes is lacking. Anastomotic leak (AL) is a main contributor to FTR. This study aimed to assess differences in FTR after AL between centers, and to identify factors that explain these differences.Methods: TENTACLE -Esophagus is a multicenter, retrospective cohort study, which included 1509 patients with AL after esophagectomy. Differences in FTR were assessed between low-volume (<20 re-sections), middle-volume (20-60 resections) and high-volume centers (>= 60 resections). Mediation analysis was performed using logistic regression, including possible mediators for FTR: case-mix, hos -pital resources, leak severity and treatment. Results: FTR after AL was 11.7%. After adjustment for confounders, FTR was lower in high-volume vs. low-volume (OR 0.44, 95%CI 0.2-0.8), but not versus middle-volume centers (OR 0.67, 95%CI 0.5-1.0). After mediation analysis, differences in FTR were found to be explained by lower leak severity, lower secondary ICU readmission rate and higher availability of therapeutic modalities in high-volume centers. No statistically significant direct effect of hospital volume was found: high-volume vs. low-volume 0.86 (95%CI 0.4-1.7), high-volume vs. middle-volume OR 0.86 (95%CI 0.5-1.4).Conclusion: Lower FTR in high-volume compared with low-volume centers was explained by lower leak severity, less secondary ICU readmissions and higher availability of therapeutic modalities. To reduce FTR after AL, future studies should investigate effective strategies to reduce leak severity and prevent sec-ondary ICU readmission.(c) 2023 The Authors.
Palavras-chave
Failure to rescue, Esophagectomy, Complications, Anastomotic leak, Practice variation
Referências
  1. Abdelsattar ZM, 2020, ANN THORAC SURG, V109, P865, DOI 10.1016/j.athoracsur.2019.09.044
  2. Al-Batran SE, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.4004
  3. Brusselaers N, 2014, GUT, V63, P1393, DOI 10.1136/gutjnl-2013-306074
  4. Bundred J, 2019, WORLD J SURG, V43, P2874, DOI 10.1007/s00268-019-05080-1
  5. Busweiler LA, 2017, EJSO-EUR J SURG ONC, V43, P1962, DOI 10.1016/j.ejso.2017.07.005
  6. Cohen P., 2013, APPL MULTIPLE REGRES, DOI [10.4324/9780203774441, DOI 10.4324/9780203774441]
  7. Damhuis RAM, 2012, BRIT J SURG, V99, P1149, DOI 10.1002/bjs.8813
  8. Dikken JL, 2012, EUR J CANCER, V48, P1004, DOI 10.1016/j.ejca.2012.02.064
  9. Ghaferi AA, 2015, BRIT J SURG, V103, P47
  10. Ghaferi AA, 2011, MED CARE, V49, P1076, DOI 10.1097/MLR.0b013e3182329b97
  11. Ghaferi AA, 2009, ANN SURG, V250, P1029, DOI 10.1097/SLA.0b013e3181bef697
  12. Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048
  13. Goense L, 2019, BRIT J SURG, V106, P111, DOI 10.1002/bjs.11000
  14. Hafeman DM, 2009, INT J EPIDEMIOL, V38, P838, DOI 10.1093/ije/dyn372
  15. Hagens ERC, 2018, ANN THORAC SURG, V106, P1702, DOI 10.1016/j.athoracsur.2018.05.009
  16. Henneman D, 2014, ANN SURG ONCOL, V21, P4068, DOI 10.1245/s10434-014-3873-5
  17. In H, 2016, ANN SURG, V263, P286, DOI 10.1097/SLA.0000000000001215
  18. Johnston MJ, 2015, SURGERY, V157, P752, DOI 10.1016/j.surg.2014.10.017
  19. Kamarajah SK, 2021, EJSO-EUR J SURG ONC, V47, P1481, DOI 10.1016/j.ejso.2020.12.006
  20. Liou DZ, 2018, ANN THORAC SURG, V105, P871, DOI 10.1016/j.athoracsur.2017.10.022
  21. Low DE, 2015, ANN SURG, V262, P286, DOI 10.1097/SLA.0000000000001098
  22. Markar SR, 2012, J GASTROINTEST SURG, V16, P1055, DOI 10.1007/s11605-011-1731-3
  23. Oesophago-Gastric Anastomosis Study Group on behalf of the West Midlands Research C, 2022, ANN SURG, V275, P382
  24. Puccetti F, 2022, DIS ESOPHAGUS, V35, DOI 10.1093/dote/doab027
  25. Richiardi L, 2013, INT J EPIDEMIOL, V42, P1511, DOI 10.1093/ije/dyt127
  26. Slankamenac K, 2013, ANN SURG, V258, P1, DOI 10.1097/SLA.0b013e318296c732
  27. Smits FJ, 2022, LANCET, V399, P1867, DOI 10.1016/S0140-6736(22)00182-9
  28. Talsma AK, 2014, ANN SURG, V260, P267, DOI 10.1097/SLA.0000000000000482
  29. The World Bank, 2022, LOW MIDDL INC DAT 20
  30. Ubels S, 2022, DIS ESOPHAGUS
  31. Ubels S, 2022, BRIT J SURG, V109, P864, DOI 10.1093/bjs/znac226
  32. van Buuren S, 2011, J STAT SOFTW, V45, P1
  33. van der Werf LR, 2020, ANN SURG, V271, P1095, DOI 10.1097/SLA.0000000000003210
  34. van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088
  35. van Lanschot JJB, 2001, CANCER-AM CANCER SOC, V91, P1574, DOI 10.1002/1097-0142(20010415)91:8<1574::AID-CNCR1168>3.0.CO;2-2
  36. van Workum F, 2021, JAMA SURG, V156, P601, DOI 10.1001/jamasurg.2021.1555
  37. Verstegen MHP, 2019, WORLD J EMERG SURG, V14, DOI 10.1186/s13017-019-0235-4
  38. Voeten DM, 2021, ANN SURG, V274, P449, DOI 10.1097/SLA.0000000000004985
  39. Wood AM, 2015, BIOMETRICAL J, V57, P614, DOI 10.1002/bimj.201400004